click below
click below
Normal Size Small Size show me how
Grad Pharm
drugs
Question | Answer |
---|---|
Acyclovir | HSV drug. Viral TK first phosphorylates. |
Cidofovir | HSV drug. Doesn't need viral TK. Less specific |
AZT | Azidothymidine. AZT-PPP Inhibits RT. Also causes chain termination |
NNRTI | Non nucleoside reverse transcriptase inhibitor. Noncompetitive inhibitor. High resistance. |
Protease Inhibitor | HIV drug. Stops protease needed to cleave viral proteins to activate them |
Pleconaril | For Rhinovirus. Block viral uncoating and attachement to epithelial cells. |
Bephenium | Antihelminthic. block reuptake of ACh. Spastic paralysis |
Pyrantel | inhibits ACh esterase. Spastic Paralysis |
Piperazine | Flaccid paralysis. Mechanism Unclear |
Metronidazole | nitroaromatic group accepts electron. Produces radical species that causes DNA damage in anerobes.Through Nitroso compounds |
Pentamidine | Anti Trypanosome. Actively pumped into parasite. |
Difluoromethylmithine (DFMO) | irreversibly binds to ornithine decarboxylase. Enzyme has long halflife in trypanazome |
Aspirin | Nonselective COX inbibitor. irreversible |
Ibuprofen, naproxen, indomethacin | Non selective COX inbibitor, reversible |
Celecoxib, rofecoxib, valdecoxib | Selective COX2 inhibitor. Rofecoxib, and valdecoxib show cardiovascular risk |
Estradiol, ethinyl estradiol, quinestrol | Agonist of estrogen |
Tamoxifen | Antagonist of estrogen, for ER positive breast cancer |
Enclomephene | Treatment for infertility. contraceptive activity |
19-nortestosterone, norethindrone, norethnodrel | Agonist of progestin. Hormone repalcement therapy |
Mifepristone RU486 | Antagonist of progestins. Abortions |
testosterone | agonist of androgen |
finasteride, flutimide | antagonist of androgen |
hydrocortisone, dexamethasone, prednisolone | agonist of adrenalcorticosteroids |
Rituximab | chimeric antibody with human constant region and mouse variable. targets and kills B-cells with CD20. for lymphoma |
Dipyridamole | Adenosine deaminase inhibitor. Anti platelet agent |
Ticlopidine | P2Y12 antagonist. Noncompetitive irreversible binding to receptor. neutropenia |
Clopidogrel | Plavix. less neutropenia P2Y12 antagonist |
Prasugrel | improve on plavix, but higher bleeding risk. |
Ticagrelor | reversible P2y12 antagonist. More bleeding. good efficacy. |
Abciximab | GPIIBIIIa receptor antagonist humanized mouse antibody |
Eptifibatide | GPIIBIIIa antagonist. RGD cyclic peptide |
Tirofiban | small molecule RGD mimic |
Vorapaxar | PAR1 (Thrombin receptor antagonist) |
Heparin | antithrombin inactivation of Factor Xa. No oral bioavailibility |
Warfarin | Vitamin K dependent process. Many indirect effects. Block glutamic acid carboxylation. Slow |
Rivaroxaban | inhibitor factor xa. orally bioavailible. long t1/2 |
Dabigatran | direct thrombin inhibitor. orally bioavailible |
Streptokinase | Fibrinolytic. Binds to plasminogen and activates it. For MI. Large dose needed. |
Altepase | Recombinant tissue Plasminogen activator (tPA). Serine protease. Short halflife. |